Showing results (91-100 of 219) with videos related to

Sort By:
Pageof 22
Regulatory Peptides|June 1, 1985
Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressureC Lebrun, M Le Moal, G F Koob, et al.
Revue Neurologique|January 1, 1993
[Ischemic encephalopathy in primary antiphospholipid syndrome]P Thomas, C Lebrun, M H Mahagne, et al.
Revue Neurologique|April 5, 2017
Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS?E K Van Obberghen, M Cohen, F Rocher, et al.
Revue Neurologique|October 17, 1998
[Orthostatic hypotension revealing vitamin B12 deficiency]P Girard, C Lebrun, F Peyrade, et al.
Revue Neurologique|April 25, 2007
[Neurosarcoidosis treated with mycophenolate mofetil: two cases]A Chaussenot, V Bourg, S Chanalet, et al.
Revue Neurologique|August 19, 2008
[Knowing without remembering: the contribution of developmental amnesia]C Lebrun-Givois, B Guillery-Girard, C Thomas-Anterion, et al.
Inorganic Chemistry|June 12, 2001
Solid state and solution studies of lanthanide(III) complexes of cyclohexanetriols, models of the coordination sites found in sugarsP Delangle, C Husson, C Lebrun, et al.
Revue Neurologique|February 29, 2000
[Chemotherapy of malignant inoperable gliomas. The association of fotemustine-cisplatine-etoposide as neoadjuvants]M Frenay, C Lebrun, M Lonjon, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
Up-front chemotherapy with fotemustine (F) / cisplatin (CDDP) / etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomasM Frenay, C Lebrun, M Lonjon, et al.
Revue Neurologique|September 24, 2008
[Approaches to segment multiple-sclerosis lesions on conventional brain MRI]J-C Souplet, C Lebrun, S Chanalet, et al.
Pageof 22